Seaport Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -5.70%
- Market cap
- $1.08B
- 53.53M shares
- Filings
- 59
—
—
—Q3 2026
—Q3 2026
—Q3 2026derived
—Q3 2026
—Q3 2026
—- $1.08B
- —
- —
- 2.7×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Seaport Therapeutics, Inc. is the 142nd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
AMPHAmphastar Pharmaceuticals, Inc.$719.9M1.7%13.6%$1.2BGHRSGH Research PLC———$1.1BJBIOJade Biosciences, Inc.———$1.1BMLTXMoonLake Immunotherapeutics———$1.1B
SPTXSeaport Therapeutics, Inc. (this company)———$1.1B
VSTMVerastem, Inc.$30.9M209.1%677.6%$1.1BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1BSVRASavara Inc———$1.0BJANXJanux Therapeutics, Inc.$10.0M5.6%1,136.3%$1.0BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Seaport Therapeutics, Inc. · CIK 2042347 · Engraved from SEC EDGAR